Reducing Patient Stress Through Chemistry
World Small Animal Veterinary Association Congress Proceedings, 2019
M. Herron
Veterinary Clinical Sciences, The Ohio State University, Columbus, OH, USA

When is Full Chemical Restraint Indicated?

Marked fear at any point or moderate fear in response to minimal handling.

  • Marked fear: Alligator rolling, flinching and vocalizing with minimal touch, releasing anal glands, urinating, flailing, panicked attempts to flee during exam, in addition to moderate fear signs. These patients should be given CR for any and all procedures until (if/when) patient can be desensitized/counter-conditioned to be more accepting of handling.
  • Moderate fear: Cowering, crouching, urinating, tail tucked, head turned away, avoiding eye contact, ears pinned back, displaying several oral displacement behaviors (harsh panting, lip licking, yawning, lip smacking). May be able to “talk these patients off the ledge” using food for counterconditioning, minimal restraint, environmental modification and handling tools; if not then opt for chemical restraint.

Severely fractious behavior at any point or moderately fractious behavior in response to minimal handling.

  • Severely fractious: Barking/lunging upon clinician’s entrance or when within immediate radius, attempts to bite, hackles up, snarling, air snapping, tail up, ears forward. These patients should be given CR for any and all procedures until (if/when) patient can be desensitized/counter-conditioned to be more accepting of handling.
  • Moderately fractious: Growls, snarls, freezes with “whale eye” at any touch, may show more defensive postures while growling and showing teeth (ears back, tail tucked, cowering). May be able to “talk these patients off the ledge” using food for counterconditioning, minimal restraint, environmental modification and handling tools; if not then opt for chemical restraint.

Known history of displaying moderate–marked fear or fractious behavior during a specific procedure. For example, a patient who shows this behavior during a previous toenail trim, rectal exam, ear cleaning, bandage change, urinary catheterization, blood draws, etc., should have CR before such procedures.

Prior to painful or socially invasive procedure, or combination of procedures, which may adversely affect the future behavior of a patient in the clinic setting. For example, CR should be given prior to pelvic radiographs, wound repair/debridement, and abdominal FNAs.

When Should CR Be Administered?

Ideally, injection should be given prior to the patient’s becoming highly aroused, agitation or fractious. If the procedure is not essential, you can plan for CR on a subsequent visit.

Oral Premedications

Oral anxiolytics/sedatives can be used as the sole method of anxiety reduction for mildly fearful patients. They can also be used prior to administration of injectable chemical restraint to reduce stress during the injection and to increase the safety of giving the injection. Oral medications should be administered at least 90 minutes prior to patients getting into the car/carrier to come to the vet clinic. Any new medication should be tested by the owner at home a few days before their scheduled visit to assess for adverse effects and ensure adequate dosing.

Table 1. Trazodone

Dose

Dogs: 4–18 mg/kg PO; not exceeding 300 mg/dose
Cats: 50–100 mg/cat

Class

Serotonin 2A antagonist/reuptake inhibitor (SARI)

MOA

Some selective inhibition of 5HT reuptake, antagonizes 5HT2A receptors, releasing 5HT1A

Onset of action

60–120 minutes

Duration of action

About 8 hours

Contraindications

Use caution in patients with severe systemic disease

Drug interactions

Do not combine with MAOIs, slight caution with other SRIs

Side effects

Likely: sedation
Possible: GI upset/bleed, agitation, urinary incontinence, changes in appetite

Shortcut dosing:
Dogs <40 lb: Start at a calculated dose between 4–6 mg/kg
Dogs >40 lb: Start at 100 mg titrated as needed up to 300 mg/dog

 

Table 2. Clonidine

Dose

Dogs: 0.01–0.05 mg/kg PO
Cats: 5–10 µg/kg PO

Class

Alpha-2 agonist

MOA

Slows release of NE in CNS, decreasing anxiety, HR, BP, pupil dilation

Onset of action

30–90 minutes

Duration of action

6–8 hours

Contraindications

Cardiovascular disease, severe renal disease, hypotensive patients

Drug interactions

Beta-blockers may enhance bradycardia, other antihypertensive drugs (Ace?)

Side effects

Likely: sedation, mild hypotension
Possible: agitation, GI upset, collapse, bradycardia

 

Table 3. Gabapentin

Dose

Dogs: 10–50* mg/kg PO
Cats: 50–200 mg/cat PO

Class

GABA analogue; anticonvulsant

MOA

Not well understood; blocks release of excitatory NTs (substance P, glutamate, NE)

Onset of action

60–90 minutes

Duration of action

6–8 hours

Contraindications

Caution in patients with renal insufficiency

Drug interactions

Antacids block absorption

Side effects

Likely: sedation

Caution: human Neurontin® oral solution contains xylitol.

Table 4. Lorazepam

Dose

Dogs: 0.05–0.5 mg/kg PO
Cats: 0.05–0.25 mg/kg PO

Class

Benzodiazepine

MOA

Potentiates GABA activity

Onset of action

30–60 minutes

Duration of action

6–8 hours

Contraindications

Severe respiratory insufficiency, aggressive patients

Drug interactions

Caution with other CNS depressants

Side effects

Likely: increased appetite, sedation
Possible: ataxia, aggression, paradoxical excitation

Caution: diazepam (benzodiazepine) has been associated with acute hepatic necrosis after PO administration in cats. No active liver metabolites in lorazepam—risk should be lower.

Table 5. Acepromazine

Dose

Dogs: 0.55–2.2 mg/kg PO
Cats: 1.1-2.2 mg/kg PO

Class

Phenothiazine tranquilizer; antipsychotic

MOA

Block postsynaptic dopamine receptors in CNS, depressing RAS (alertness)

Onset of action

30–90 minutes

Duration of action

8–12 hours

Contraindications

Seizures?, severe cardiovascular disease, hypotensive patients, aggressive patients?

Drug interactions

Antacids block absorption, caution with other CNS depressants

Side effects

Likely: sedation, hypotension
Possible: collapse, seizures, bradycardia, agitation, noise sensitivity

Best used in combination with an anxiolytic drug—does not provide anxiolysis.

Common oral premed cocktails for dogs:
Trazodone + clonidine
Trazodone + gabapentin
Trazodone + acepromazine
Trazodone + clonidine + gabapentin
Trazodone + acepromazine + gabapentin
*Lorazepam can be added to any of the above combinations in non-fractious patients. All are safe premeds for injectable sedation in healthy dogs.

Oral premed cocktails for cats:
Lorazepam + acepromazine
Acepromazine + gabapentin
Lorazepam + gabapentin

Chemical Restraint—Injectables

Table 6. Dexdomitor® (dexmedetomidine)

Dose

Dogs: 4–20 µg/kg IM, 40 µg/kg OTM
Cats: 10–40 µg/kg IM or OTM

Class

Alpha-2 agonist

MOA

Very specific for alpha-2 receptors in CNS, causing major CNS depression

Onset of action

5–15 minutes (IM); 30–60 minutes (OTM)

Duration of action

45–60 minutes

Contraindications

Cardiovascular disease, severe renal disease

Drug interactions

Caution with high doses of acepromazine and CNS depressants

Side effects

Bradycardia, vasoconstriction, hypothermia, pale mm, respiratory depression

Reverse dexmedetomidine with half volume of atipamezole to volume of dexmedetomidine administered IM.

Table 7. Torbugesic® (butorphanol)

Dose

0.1–0.5 mg/kg IM, IV, or SC—dogs and cats

Class

Opiate partial agonist

MOA

Partially agonizes/antagonizes µ and opioid receptors, subcortical and spinal analgesia

Onset of action

3 minutes (IV)–15 minutes (IM, SC)

Duration of action

1–4 hours

Contraindications

Severe renal insufficiency, severely debilitated patients

Drug interactions

May enhance CNS depressant effects of other CNS depressants; will partially reverse full opioid agonists

Side effects

Sedation, mild bradycardia, mild respiratory depression, mild ataxia

 

Table 8. Ketamine

Dose

1–5 mg/kg IM—dogs and cats

Class

Dissociative general anesthetic

MOA

NMDA receptor antagonist

Onset of action

5–10 minutes

Duration of action

1 hour

Contraindications

Hypertensive patients, CHF; caution in epileptic patients

Drug interactions

Caution with other CNS depressants

Side effects

Anesthesia, respiratory depression, seizures, dysphoria, myoclonic jerking

 

Table 9. Acepromazine

Dose

1–5 mg/kg IM—dogs and cats

Class

Dissociative general anesthetic

MOA

NMDA receptor antagonist

Onset of action

5–10 minutes

Duration of action

1 hour

Contraindications

Hypertensive patients, CHF; caution in epileptic patients

Drug interactions

Caution with other CNS depressants

Side effects

Anesthesia, respiratory depression, seizures, dysphoria, myoclonic jerking

 

Table 10. Midazolam

Dose

0.2–0.4 mg/kg IM or IV—dogs and cats

Class

Benzodiazepine

MOA

Potentiates GABA activity;

Onset of action

3–5 minutes

Duration of action

1–2 hours

Contraindications

Severe respiratory insufficiency, aggressive patients

Drug interactions

Caution with other CNS depressants

Side effects

Likely: Increased appetite, sedation, muscle relaxation
Possible: ataxia, aggression, paradoxical excitation

 

Table 11. Telazol® (tiletamine/zolazepam)

Dose

5–10 mg/kg IM—dogs* and cats

Class

Dissociative general anesthetic/benzodiazepine

MOA

NMDA receptor antagonist/potentiates GABA activity

Onset of action

3–5 min

Duration of action

30–60 min

Contraindications

Pancreatic disease, severe cardiac or respiratory disease

Drug interactions

Caution with other CNS depressants

Side effects

Anesthesia, respiratory depression, jerky recovery possible, but less likely than with ketamine

 

How do we get the injection into the dog?
Drive-by sedation (aka “ninja stab”)
Squeeze cage option
Can also use a door and adjacent wall—less for smaller patients

Injection administration for cats
Ideally can keep cat corralled in own carrier
Can give IM injection through soft, mesh carrier
Can lift top off of hard carrier and use towel to restrain for quick IM injection (a bit riskier)
Can use EZ Nabber to restrain and give IM injection through the mesh
Achieving and maintaining adequate sedation

Visual blocking: Avoid lobby time if at all possible; use Calming Cap or carrier cover to reduce visual input before/during/after injection; keep room dark after injection.

Auditory blocking: Play classical music and white noise; minimize talking; use room away from lobby and treatment areas; place cotton balls in ears after injection.

Tactile: No touching after injection; avoid moving patient until fully sedate.

Olfactory: Have pheromones applied to room ahead of time.

Keeping Track

Write down drugs, doses and time each medication given (including oral meds given at home).

References

1.  Herron M, Shreyer T. Fear and Aggression in Veterinary Visits. Blackwell’s Five-Minute Veterinary Consult: Canine and Feline. 6th ed. 2015:484–487.

2.  Herron M, Shreyer T. Blackwell’s Five-Minute Veterinary Consult Clinical Companion: Canine and Feline Behavior. 2nd ed. In Press.

 

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

M. Herron
Veterinary Clinical Sciences
The Ohio State University
Columbus, OH, USA


MAIN : WSAVA Welfare Low Stress Handling : Reducing Patient Stress Through Chemistry
Powered By VIN
SAID=27